UBS Reiterates Rentokil Initial (RKLIF) Neutral Recommendation

Fintel reports that on October 17, 2025, UBS reiterated coverage of Rentokil Initial (OTCPK:RKLIF) with a Neutral recommendation. Analyst Price Forecast Suggests 10.14% Upside https://www.nasdaq.com/articles/ubs-reiterates-rentokil-initial-rklif-neutral-recommendation